PlateletBio Names Dr. Steven Altschuler as Chairman of its Board of Directors

PlateletBio Names Dr. Steven Altschuler as Chairman of its Board of Directors

PlateletBio, a pioneering biotechnology company developing next-generation allogeneic cell therapies for treatment of human diseases, has named Steven M. Altschuler, M.D., as Chairman of its Board of Directors. Read more >>

Share this post